Citation Impact
Citing Papers
Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria
2006
Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research.
2009 Standout
Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.
2003
Age-related difference in susceptibility of ApcMin/+ mice towards the chemopreventive efficacy of dietary aspirin and curcumin
2003
4-Hydroxy-3-Methoxybenzoic Acid Methyl Ester: A Curcumin Derivative Targets Akt/NFκB Cell Survival Signaling Pathway: Potential for Prostate Cancer Management
2003
Consumption of the Putative Chemopreventive Agent Curcumin by Cancer Patients: Assessment of Curcumin Levels in the Colorectum and their Pharmacodynamic Consequences
2005
Dietary Curcuminoids Prevent High-Fat Diet–Induced Lipid Accumulation in Rat Liver and Epididymal Adipose Tissue
2001
Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin
2002
Sensitive and rapid isocratic liquid chromatography method for the quantitation of curcumin in plasma
2003
Effect of azoxymethane and curcumin on transcriptional levels of cyclooxygenase-1 and -2 during initiation of colon carcinogenesis
2006
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
A realistic clinical perspective of tamoxifen and endometrial carcinogenesis
1996
Molecular Understanding and Modern Application of Traditional Medicines: Triumphs and Trials
2007 Standout
Suppression of Altered Hepatic Foci Development by Curcumin in Wistar Rats
2003
A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation
1999 Standout
Synthesis and Antitumor Activity of Some Curcumin Analogs
2005
Studies on the in vitro absorption of spice principles – Curcumin, capsaicin and piperine in rat intestines
2007
Balancing Acts
2004 Standout
State of the art in the delivery of photosensitizers for photodynamic therapy
2002
Tetrahydrocurcumin in plasma and urine: Quantitation by high performance liquid chromatography
2005
Porphyrias
2010 Standout
Curcumin as “Curecumin”: From kitchen to clinic
2007 Standout
Homozygous Variegate Porphyria: 20 y Follow-Up and Characterization of Molecular Defect
2001
Congenital Erythropoietic Porphyria
1998
Mutations in human CPO gene predict clinical expression of either hepatic hereditary coproporphyria or erythropoietic harderoporphyria
2005
Curcumin blocks multiple sites of the TGF-β signaling cascade in renal cells
2004
Photodynamic therapy for cancer
2003 Standout
Cyclooxygenase-2 expression and oxidative DNA adducts in murine intestinal adenomas: Modification by dietary curcumin and implications for clinical trials
2006
Oral flavonoids delay recovery from experimental autoimmune encephalomyelitis in SJL mice
2005
Temoporfin (Foscan®, 5,10,15,20‐Tetra(m‐hydroxyphenyl)chlorin)—A Second‐generation Photosensitizer†,‡
2011
Role of two nutritional hepatic markers (insulin‐like growth factor 1 and transthyretin) in the clinical assessment and follow‐up of acute intermittent porphyria patients
2009
Induction of Apoptosis by Curcumin and Its Implications for Cancer Therapy
2005
Mutant ATP-binding RNA aptamers reveal the structural basis for ligand binding
1997 StandoutNobel
Effects of chloroquine in hematoporphyrin-treated animals
1996
Preparation of isotopically labeled ribonucleotides for multidimensional NMR spectroscopy of RNA
1992
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
2006 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
Metal-mediated DNA damage induced by curcumin in the presence of human cytochrome P450 isozymes
2002
ALCOHOL AND PORPHYRIN METABOLISM
2000
Clinical potential of new antiestrogens.
1997
Systematic analysis of coproporphyrinogen oxidase gene defects in hereditary coproporphyria and mutation update
1999
Dose escalation of a curcuminoid formulation
2006 Standout
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Does tamoxifen cause cancer in humans?
1998
Two to Tango: Regulation of Mammalian Iron Metabolism
2010 Standout
Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor‐κB signaling
2004
Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo
2004 Standout
Curcumin Suppresses Interleukin 1β-Mediated Microsomal Prostaglandin E Synthase 1 by Altering Early Growth Response Gene 1 and Other Signaling Pathways
2005
Curcumin: The story so far
2005 Standout
A facile and versatile preparation of bilindiones and biladienones from tetraarylporphyrins
2005 StandoutNobel
Recommendations for Improving Serum Creatinine Measurement: A Report from the Laboratory Working Group of the National Kidney Disease Education Program
2005
Inhibition of Colonic Aberrant Crypt Foci by Curcumin in Rats Is Affected by Age
2004
Detection and quantitation of curcumin in mouse lung cell cultures by matrix-assisted laser desorption ionization time of flight mass spectrometry
2004
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
1998 Standout
Curcumin modulation of Na,K‐ATPase: phosphoenzyme accumulation, decreased K+ occlusion, and inhibition of hydrolytic activity
2005
Suppression of protein kinase c and nuclear oncogene expression as possible action mechanisms of cancer chemoprevention by curcumin
2004
High‐performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin
2007
Photodynamic therapy and anti-tumour immunity
2006 Standout
Iron chelation in the biological activity of curcumin
2005
Inhibition by dietary dibenzoylmethane of mammary gland proliferation, formation of DMBA–DNA adducts in mammary glands, and mammary tumorigenesis in Sencar mice
2001
The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen
1998 Standout
Identification and characterization of novel uroporphyrinogen decarboxylase gene mutations in a large series of porphyria cutanea tarda patients and relatives
2009
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Effective Gene Therapy of Mice with Congenital Erythropoietic Porphyria Is Facilitated by a Survival Advantage of Corrected Erythroid Cells
2008
Differential Regulation of Cytokines and Transcription Factors in Liver by Curcumin Following Hemorrhage/Resuscitation
2003
Innovative Agents in Cancer Prevention
2005
Modern Synthetic Methods for Fluorine‐Substituted Target Molecules
2004 Standout
Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration
2004
Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins
2008
Chemopreventive Properties of Curcumin
2005
DISTRIBUTION OF TEMOPORFIN, A NEW PHOTOSENSITIZER FOR THE PHOTODYNAMIC THERAPY OF CANCER, IN A MURINE TUMOR MODEL
1995
Glucuronidation of curcuminoids by human microsomal and recombinant UDP‐glucuronosyltransferases
2007
Biological Properties of Curcumin-Cellular and Molecular Mechanisms of Action
2004
Mechanisms in photodynamic therapy: Part three—Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction
2005
Uroporphyrinogen decarboxylase
1995
CURCUMIN: THE INDIAN SOLID GOLD
2007 Standout
Cancer chemoprevention by dietary constituents: a tale of failure and promise
2001
Biochemical differentiation of the porphyrias
1999
Congenital erythropoietic porphyria
1997
Cyclooxygenase isozymes and their gene structures and expression
2002
Indirect detection of photosensitizer ex vivo
2002
Curcumin–phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats
2006
Ultrasonically assisted electrospray ionization for LC/MS determination of nucleosides from a transfer RNA digest
1994 StandoutNobel
The Yeast HAL2 Nucleotidase Is an in Vivo Target of Salt Toxicity
1996
Curcumin: From ancient medicine to current clinical trials
2008 Standout
Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine
2006
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Electrospray Ionization for Mass Spectrometry of Large Biomolecules
1989 StandoutScienceNobel
Self-association of Disulfonated Deuteroporphyrin and its Esters in Aqueous Solution and Photosensitized Production of Singlet Oxygen by the Dimers¶
2002
Bioavailability of Curcumin: Problems and Promises
2007 Standout
Gut Microbiota in Health and Disease
2010 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Spectroscopic studies of photobleaching and photoproduct formation of meta(tetrahydroxyphenyl)chlorin (m-THPC) used in photodynamic therapy. The production of singlet oxygen by m-THPC
1998
Photobleaching of sensitisers used in photodynamic therapy
2001
Physical Mechanisms of Generation and Deactivation of Singlet Oxygen
2003 Standout
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Rv2131c fromMycobacterium tuberculosisIs a CysQ 3′-Phosphoadenosine-5′-phosphatase
2008 StandoutNobel
Anticancer potential of curcumin: preclinical and clinical studies.
2003 Standout
Curcumin inhibits telomerase activity in human cancer cell lines
2006
Bright Side of Lignin Depolymerization: Toward New Platform Chemicals
2018 Standout
Phase I Clinical Trial of Oral Curcumin
2004
Analytical Reviews in Clinical Biochemistry: The Estimation of Creatinine
1986
Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate
2006 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Nanoparticles in Photodynamic Therapy
2015 Standout
Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer.
2002
Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine.
2002
Mycolic Acid Analysis by High-Performance Liquid Chromatography for Identification ofMycobacteriumSpecies
2001
A Salt-Sensitive 3′(2′),5′-Bisphosphate Nucleotidase Involved in Sulfate Activation
1995 Science
A mouse model of familial porphyria cutanea tarda
2000
Diagnostic Strategies for Autosomal Dominant Acute Porphyrias: Retrospective Analysis of 467 Unrelated Patients Referred for Mutational Analysis of the HMBS, CPOX, or PPOX Gene
2009
[13C,13C]- and [13C,1H]-TROSY in a Triple Resonance Experiment for Ribose−Base and Intrabase Correlations in Nucleic Acids1
2001 StandoutNobel
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
2020
Biosynthesis of Apolipoprotein B48-containing Lipoproteins
1996 StandoutNobel
BODIPY dyes in photodynamic therapy
2012 Standout
Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis.
2002
Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer.
2001
5-Aminolaevulinic acid-induced protoporphyrin IX accumulation in tissues: pharmacokinetics after oral or intravenous administration
1998
Serum Creatinine as an Index of Renal Function: New Insights into Old Concepts
1992 Standout
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Effects of dietary curcumin on glutathione S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: relationship with drug levels.
2001
Curcumin ameliorates ethanol and nonethanol experimental pancreatitis
2003
Biliverdin reductase: A major physiologic cytoprotectant
2002 Standout
The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life.
1989
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Molecular and Biochemical Studies of Acute Intermittent Porphyria in 196 Patients and Their Families
2002
Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agents.
2001
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
2013 StandoutNobel
Metabolism of Curcuminoids in Tissue Slices and Subcellular Fractions from Rat Liver
2006
Curcuminoids Form Reactive Glucuronides In Vitro
2006
Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models
2004
Interplay between MRP Inhibition and Metabolism of MRP Inhibitors: The Case of Curcumin
2003
Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 2. Clinical Considerations and New Agents
2003
Determination of sulfonated azo dyes by liquid chromatography/atmospheric pressure ionization mass spectrometry
1987
Significance of apoptosis and its relationship to antioxidants after ochratoxin A administration in mice.
2001
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
2003 Standout
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Hereditary coproporphyria: Comparison of molecular and biochemical investigations in a large family
2005
The little imitator--porphyria: a neuropsychiatric disorder.
1997
Creatine and Creatinine Metabolism
2000 Standout
Neonatal Hemolytic Anemia Due to Inherited Harderoporphyria: Clinical Characteristics and Molecular Basis
1998
Elucidation of Anti-allergic Activities of Curcumin-Related Compounds with a Special Reference to Their Anti-oxidative Activities
2005
High-performance liquid chromatographic separation and quantitation of tetrapyrroles from biological materials
1986
Works of C.K. Lim being referenced
Pulmonary availability of isotretinoin in rats after inhalation of a powder aerosol
2000
Photodynamic therapy with mTHPC and polyethylene glycol-derived mTHPC: a comparative study on human tumour xenografts
1999
Coproporphyrinogen oxidase, protoporphyrinogen oxidase and ferrochelatase activities in iron‐overloaded and ethanol‐treated rats
1990
Genotoxicity of tamoxifen epoxide and toremifene in human lymphoblastoid cells containing human cytochrome P450s
1994
Isocractic reversed-phase high-performance liquid chromatography of ribonucleotides, deoxynucleotides, cyclic nucleotides and deoxycyclic nucleotides
1989
Coproporphyrinogen oxidase, protoporphyrinogen oxidase and ferrochelatase activities in human liver biopsies with special reference to alcoholic liver disease
1989
Study of temoporfin metabolism by HPLC and electrospray mass spectrometry
1999
Determination of 5,10,15,20‐tetra‐(m‐hydroxyphenyl) chlorin in tissues by high performance liquid chromatography
1993
Accurate and specific HPLC assay of coproporphyrinogen III oxidase activity in human peripheral leucocytes
1988
Analysis of urine and faecal porphyrins by HPLC coupled to an advanced automated sample processor
1986
Preparation, high-performance liquid chromatographic separation and characterization of hexacarboxylic porphyrinogens
1989
Comparison of HPLC, capillary electrophoretic and direct spectrofluorimetric methods for the determination of temoporfin–poly(ethylene glycol) conjugates in plasma†
1998
High performance liquid chromatographic studies of erythrocyte haem biosynthetic enzyme activities in alcoholic macrocytosis
1990
High-performance liquid chromatography of uroporphyrinogen and coproporphyrinogen isomers with amperometric detection
1986
Separation of porphyrin isomers by high-performance liquid chromatography
1983
Congenital erythropoietic uroporphyria (Günther's disease) presenting in a middle aged man
1978
High-performance liquid chromatography of naturally occurring 8-, 7-, 6-, 5- and 4-carboxylic porphyrin isomers
1983
Simultaneous determination of hydroxymethylbilane synthase and uroporphyrinogen III synthase in erythrocytes by high-performance liquid chromatography
1983
High Pressure Liquid Chromatography in Clinical Chemistry: A Review
1976
In vitro and in vivo metabolism of 5,10,15,20-tetra (m-hydroxyphenyl)chlorin in rats and humans
1999
Normal-phase high-performance liquid chromatography of porphyrin free acids on silica modified with tetraethylenepentamine
1982
Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.
2001
Ammonium acetate: A general purpose buffer for clinical applications of high-performance liquid chromatography
1984
High-performance liquid chromatography of dicarboxylic porphyrins and metalloporphyrins: retention behaviour and biomedical applications
1984
Comparative study of several phase systems for the high-performance liquid chromatographic separation of monoiodoinsulins
1985
Urine and faecal porphyrin profiles by reversed-phase high-performance liquid chromatography in the porphyrias
1984
Identification of photochemical oxidation products of 5,10,15,20-tetra(m-hydroxyphenyl)chlorin by on-line high-performance liquid chromatography-electrospray ionization tandem mass spectrometry
1996
Towards a definitive assay of creatinine in serum and in urine: separation by high-performance liquid chromatography
1978
Order of uroporphyrinogen III decarboxylation on incubation of porphobilinogen and uroporphyrinogen III with erythrocyte uroporphyrinogen decarboxylase
1993